Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation

Journal of Immunology

Volumn 166, Issue 7, 2001, Pages 4780-4787

  Takasaki, Y ^a   Kogure, T ^a   Takeuchi, K ^a   Kaneda, K ^a   Yano, T ^a   Hirokawa, K ^a   Hirose, S ^a   Shirai, T ^a   Hashimoto, H ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 5; CYCLINE; DNA TOPOISOMERASE; HELICASE; MONOCLONAL ANTIBODY; PROTEIN P21; REPLICATION PROTEIN A;

AFFINITY CHROMATOGRAPHY; ANTIBODY PRODUCTION; AUTOIMMUNITY; CELL CYCLE; CELL PROLIFERATION; COMPLEX FORMATION; DNA REPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 0035313126     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.7.4780     Document Type: Review

References (53)

1. Autoantibody to a nuclear antigen in proliferating cells
2. Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera
3. Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies
4. A nuclear antigen associated with cell proliferation and blast transformation: Its distribution in synchronized cells
5. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ
6. The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro
7. Purification of PCNA as a nucleotide excision repair protein
8. Proliferating cell nuclear antigen is required for DNA excision repair
9. Nucleotide excision repair DNA synthesis by DNA polymerase ε in the presence of PCNA, RFC, and RPA
10. Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA
11. Studies on the interactions between human replication factor C and human proliferating cell nuclear antigen
12. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA
13. D-type cyclin-binding regions of proliferating cell nuclear antigen
14. Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA
15. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1
16. Replication-dependent marking of DNA by PCNA facilitates CAF-1-coupled inheritance of chromatin
17. Inhibition of nuclear DNA synthesis by autoantibody to proliferating cell nuclear antigen/cyclin
18. Autoantibodies to the proliferating cell nuclear antigen neutralizes the activity of the auxilliary protein for DNA polymerase δ
19. Involvement of proliferating cell nuclear antigen (Cyclin) in DNA replication in living Cells
20. Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication
21. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): Structural conservation and the detection of a nucleolar form
22. A sandwich type enzyme-linked immunosorbent assay for proliferating cell nuclear antigen (PCNA/cyclin) using monoclonal antibodies
23. Detection of proliferating cell nuclear antigen (PCNA) in peripheral blood mononuclear cells and sera of patients with malignant lymphoma
24. Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients
25. The relationship of the proliferating cell nuclear antigen protein to cis-diamminedichloroplatinum(II) resistance of a murine leukemia cell line P338/CDDP
26. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: Comparison with histopathological parameter
27. Growth dynamics of acquired melanocytic nevi: Higher reactivity of proliferating cell nuclear antigen in junctional and compound nevi than intradermal nevi
28. Prognostic value of proliferating cell nuclear antigen (PCNA) imunostaining in neuroblastoma
29. Autoantigenic epitopes of the B and D polypeptides of the U1 snRNP: Analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera
30. Purification and characterization of Ki antigen and detection of anti-Ki antibody by enzyme-linked immunosorbent assay in patients with systemic lupus erythematosus
31. Protein measurement with the Folin phenol reagent
32. Insight into native epitopes of proliferating cell nuclear antigen using recombinant protein products
33. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies
34. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation
35. Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro
36. The interdomain connector loop of human PCNA is involved in a direct interaction with human polymerase δ
37. Mutations in yeast proliferating cell nuclear antigen define distinct sites for interaction with DNA polymerase δ and DNA polymerase ε
38. Processing of branched DNA intermediates by a complex of human FEN-1 PCNA
39. An interaction between DNA ligase I and proliferating cell nuclear antigen: Implications for Okazaki fragment synthesis and joining
40. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis
41. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
42. Identification of DNA replication and cell cycle proteins that interact with PCNA
43. Further characterization of the human cell multiprotein DNA replication complex
44. Trimeric structure of human proliferating cell nuclear antigen
45. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology
46. PCNA binding proteins
47. Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibodies and murime monoclonal antibody
48. Clinical significance of antibodies to PCNA
49. Identification of a mammalian RNA polymerase I holoenzyme containing components of the DNA repair/replication system
50. The proteasome: A protein-destroying machine
51. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway
52. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway
53. Ubiquitination of p27 is regulated by Cdk-dependent phos-phorylation and trimeric complex formation